Equity-method investment losses and pressure on earnings
First written in FY2020-Q3. 8 of 14 entries say "Mitigated", first in FY2021-Q1. Latest entry: 2026-05-11.
The whole theme swung hardest in 2019: 2 of 7 companies on the "Worse" side.
10 other companies' latest entry also says "Mitigated".
- 2026-05-11MitigatedEarnings
「Reference) Share of profit (loss) of entities accounted for using the equity method Fiscal year ended March 2026 ¥0 million Fiscal year ended March 2025 △¥44 million」
Equity-method investment income and loss improved from a loss in the previous fiscal year to zero in the current fiscal year. - FY2026-H1MitigatedAnnual report
「Equity-method investment loss 38 15」
The equity-method investment loss decreased from ¥38 million in the same period of the previous fiscal year to ¥15 million, reducing the scale of the earnings pressure. - FY2023MitigatedAnnual report
「Equity-method investment income 44」
The company shifted from an equity-method investment loss of ¥249 million in the previous fiscal year to equity-method investment income of ¥44 million in the current fiscal year, easing the earnings pressure factor. - FY2023-Q3MitigatedAnnual report
「Equity-method investment income － 64 Equity-method investment loss 22 －」
Against an equity-method investment loss of ¥22 million in the same period of the previous fiscal year, the company recorded equity-method investment income of ¥64 million for the nine months ended the third quarter of the current fiscal year, eliminating the earnings pressure factor from equity-method investments. - FY2023-Q1WorsenedAnnual report
「Equity-method investment income 157 18」
Equity-method investment income decreased from ¥157 million in the same period of the previous fiscal year to ¥18 million, weakening the earnings contribution from equity-method investments. - FY2022WorsenedAnnual report
「Equity-method investment loss 249」
The company recorded equity-method investment income of ¥671 million in the previous fiscal year, but recorded an equity-method investment loss of ¥249 million in the current fiscal year, causing the earnings pressure factor to recur. - FY2022-Q3WorsenedAnnual report
「Equity-method investment income 558 － Equity-method investment loss － 22」
Against equity-method investment income of ¥558 million in the nine months ended the third quarter of the previous fiscal year, the company recorded an equity-method investment loss of ¥22 million in the same period of the current fiscal year, causing earnings pressure to re-emerge. - FY2022-Q1RestatedAnnual report
「Equity-method investment income 174 157」
Equity-method investment income decreased from ¥174 million in the same period of the previous fiscal year to ¥157 million in the first quarter of the current fiscal year, while the shift to profit following the equity-method investment loss recorded in the previous fiscal year continued. - FY2021MitigatedAnnual report
「Equity-method investment income 671」
The company shifted from an equity-method investment loss of ¥2,115 million in the previous fiscal year to equity-method investment income of ¥671 million in the current fiscal year, eliminating the earnings pressure factor. - FY2021-Q3MitigatedAnnual report
「Equity-method investment income － 558」
Against an equity-method investment loss of ¥2,021 million in the same period of the previous year, the company recorded equity-method investment income of ¥558 million for the nine months ended the third quarter of the current fiscal year, with the earnings pressure from equity-method investments continuing to abate. - FY2021-Q2MitigatedAnnual report
「Equity-method investment income 327」
The company shifted from an equity-method investment loss of ¥2,012 million in the same period of the previous year to equity-method investment income of ¥327 million in the six months ended the second quarter of the current fiscal year, temporarily eliminating the earnings pressure. - FY2021-Q1MitigatedAnnual report
「Equity-method investment income 174」
Against an equity-method investment loss of ¥2,027 million recorded in the same period of the previous year, the company recorded equity-method investment income of ¥174 million in the first quarter of the current fiscal year, temporarily eliminating the earnings pressure from equity-method investments. - FY2020WorsenedAnnual report
「Ordinary income was ¥4,464 million, down 36.9% from the previous fiscal year, mainly because the company recorded an equity-method investment loss and other items.」
The company recorded a full-year equity-method investment loss of ¥2,115 million, reducing ordinary income by 36.9% year on year. The associate ユニバーサル製缶 also recorded a net loss for the fiscal year. - FY2020-Q3First statedAnnual report
「As a result, for the first nine months of the current consolidated fiscal year, net sales were ¥98,508 million, down 0.3% year on year, while operating profit was ¥5,633 million, down 10.4%. However, due to the recognition of an equity-method investment loss as a non-operating expense, ordinary profit was ¥3,733 million, down 45.2%, and quarterly net income attributable to owners of the parent was ¥2,664 million, down 43.9%.」
The company recognized an equity-method investment loss of ¥2,021 million as a non-operating expense, lowering ordinary income and quarterly net income attributable to owners of the parent, and identified the event as a new risk and performance factor.